Pentacenequinones

6,13-Pentacenequinone, 99%

CAS: 3029-32-1 Molecular Formula: C₂₂H₁₂O₂ Molecular Weight (g/mol): 308.34 MDL Number: MFCD00003709 InChI Key: UFCVADNIXDUEFZ-UHFFFAOYSA-N Synonym: 6,13-pentacenequinone,6,13-pentacenedione,acmc-209hec,ufcvadnixduefz-uhfffaoysa PubChem CID: 76415 IUPAC Name: pentacene-6,13-dione SMILES: C1=CC=C2C=C3C(=CC2=C1)C(=O)C4=CC5=CC=CC=C5C=C4C3=O

6,13-Pentacenedione 95.0+%, TCI America™

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

CAS: 3029-32-1 Molecular Formula: C22H12O2 Molecular Weight (g/mol): 308.336 MDL Number: MFCD00003709 InChI Key: UFCVADNIXDUEFZ-UHFFFAOYSA-N Synonym: 6,13-pentacenequinone,6,13-pentacenedione,acmc-209hec,ufcvadnixduefz-uhfffaoysa PubChem CID: 76415 IUPAC Name: pentacene-6,13-dione SMILES: C1=CC=C2C=C3C(=CC2=C1)C(=O)C4=CC5=CC=CC=C5C=C4C3=O

5,7,12,14-Pentacenetetrone 95.0+%, TCI America™

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

CAS: 23912-79-0 Molecular Formula: C22H10O4 Molecular Weight (g/mol): 338.318 MDL Number: MFCD00075209 InChI Key: YZOGOBWHTVNKGA-UHFFFAOYSA-N Synonym: 5,7,12,14-pentacenetetrone,2.3-phthalylanthrachinon,pentacene-5,7,12,14-tetraone,5,7,12,14-tetraoxo-5,7,12,14-tetrahydropentacene,5,7,12,14-tetrahydropentacene-5,7,12,14-tetrone PubChem CID: 4733 IUPAC Name: pentacene-5,7,12,14-tetrone SMILES: C1=CC=C2C(=C1)C(=O)C3=CC4=C(C=C3C2=O)C(=O)C5=CC=CC=C5C4=O

Sigma Aldrich 2-chloro-4-iodo-1-methylbenzene

MilliporeSigma Sigma Organics products encompass a wide range of quality reagents, solvents, catalysts, and building blocks for organic synthesis. From benchtop discovery to process development and scale-up, Sigma Organics solutions are built to meet the needs of synthetic chemists.

Medchemexpress LLC N-((6,7-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine | 1454585-06-8 | MFCD30187527 | 99.7% | 480.45 | C23H19F3N8O | 50 MG

SR-3029 is a potent, ATP-competitive inhibitor of casein kinase 1 isoforms CK1δ and CK1ε used for biochemical and pharmacological research. It demonstrates nanomolar inhibition of CK1δ and sub-micromolar inhibition of CK1ε, with reported Ki values and documented activity in both cell-based assays and in vivo xenograft models.

• Potent ATP-competitive inhibition of CK1δ and CK1ε.
• Nanomolar activity suitable for biochemical assays.
• Reported Ki of 97 nM for target binding.
• Validated in cell-based and in vivo xenograft studies.
• High purity to support reliable experimental results.
• Supplied as a stable solid for laboratory use.

Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More

Medchemexpress LLC N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-9-(3-fluorophenyl)-2-morpholin-4-ylpurin-6-amine | 1454585-06-8 | MFCD30187527 | 99.7% | 480.4 g/mol | C23H19F3N8O | 1 ML

SR-3029 is a potent, ATP-competitive inhibitor of casein kinase 1 delta (CK1δ) and epsilon (CK1ε) for biochemical and cellular research. It exhibits nanomolar activity and is supplied as a 10 mM solution in DMSO for laboratory use.

• Potent ATP-competitive inhibitor of CK1δ and CK1ε.
• IC50: CK1δ 44 nM; CK1ε 260 nM.
• Ki 97 nM for both kinases.
• Provided as a 10 mM solution in DMSO (1 mL).
• High purity (>99.7%) suitable for research applications.
• Useful for biochemical assays and cellular kinase studies.

Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More

Medchemexpress LLC N-[(6,7-difluoro-1H-benzimidazol-2-yl)methyl]-9-(3-fluorophenyl)-2-(4-morpholinyl)-9H-purin-6-amine | 1454585-06-8 | MFCD30187527 | 99.7% | 480.45 g/mol | C23H19F3N8O | 10 MG

SR-3029 is a potent, ATP-competitive small-molecule inhibitor of casein kinase 1 delta (CK1δ) and epsilon (CK1ε) used as a research reagent in biochemical and cell-based studies. It shows low-nanomolar activity against CK1δ and selective activity against CK1ε, with additional reported activity across certain CDKs and FLT3 in kinase profiling.

• Potent ATP-competitive inhibition of CK1δ and CK1ε (IC50 44 nM and 260 nM).
• Ki of 97 nM for both CK1δ and CK1ε.
• High purity suitable for biochemical and cell-based assays.
• Available in multiple solid sizes and as DMSO solution for assay preparation.
• Supplied as a white to pink solid for ease of handling and storage.
• Molecular weight 480.45 g/mol, facilitating dose calculation.
• For research use only; not for human or clinical use.

Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More

TARGETMOL CHEMICALS INC SR-3029 10MG

Also available in 1 mg 2 mg 5 mg 25 mg 50 mg 100 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. SR-3029 is a potent and highly specific CK1(delta)/CK1(epsilon) inhibitor. purity: 100%

Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More

Selleck Chemical LLC SR-3029

SR-3029 is a potent and selective casein kinase 1 /1 (CK1 / ) inhibitor with IC50 values of 44 and 260 nM for CK1 and CK1 respectively

Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More

Medchemexpress LLC N-((6,7-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine | 1454585-06-8 | MFCD30187527 | 99.7% | 480.45 | C23H19F3N8O | 5 MG

SR-3029 is a small-molecule, ATP-competitive inhibitor selective for casein kinase 1 delta and epsilon (CK1δ/CK1ε). It is used as a research tool compound to study CK1-dependent signaling pathways and to evaluate antiproliferative effects in preclinical models.

• Selective CK1δ/CK1ε inhibition with IC50 values in the low-nanomolar range.
• ATP-competitive mechanism useful for kinase-targeting studies.
• High chemical purity (99.73%).
• Supplied as a solid suitable for formulation and in vitro assays.
• Well-characterized structural identifiers (CAS, SMILES, MFCD) for unambiguous identification.

Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More

Medchemexpress LLC N-[(6,7-difluoro-1h-benzimidazol-2-yl)methyl]-9-(3-fluorophenyl)-2-(4-morpholinyl)-9h-purin-6-amine | 1454585-06-8 | MFCD30187527 | 99.7% | 480.45 g·mol⁻¹ | C23H19F3N8O | 25 MG

SR-3029 is a potent, ATP-competitive inhibitor of casein kinase 1 delta (CK1δ) and epsilon (CK1ε) with characterized biochemical, cellular, and in vivo activity. It is used in kinase signaling and oncology research to probe CK1-dependent pathways and evaluate antiproliferative effects in cell and animal models.

• Potent ATP-competitive inhibitor of CK1δ and CK1ε (IC50s 44 nM and 260 nM).
• Ki of 97 nM against CK1 isoforms.
• Cellular antiproliferative activity with EC50s in the low nanomolar range.
• Demonstrated antitumor activity in multiple xenograft models.
• High reported purity (99.73%).
• Available as solid and solution formats for biochemical and cell-based assays.

Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More

Medchemexpress LLC N-((6,7-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine | 1454585-06-8 | MFCD30187527 | 99.7% | 480.45 | C23H19F3N8O | 100 MG

SR-3029 is a small-molecule, ATP-competitive inhibitor of casein kinase 1 delta (CK1δ) and casein kinase 1 epsilon (CK1ε), intended for research use in biochemical and cell-based studies. It exhibits potent enzyme inhibition and is provided in formats suitable for assay and formulation work.

• Potent ATP-competitive inhibition of CK1δ and CK1ε.
• Low-nanomolar activity against CK1δ (IC50 44 nM).
• Sub-micromolar activity against CK1ε (IC50 260 nM).
• Ki of 97 nM for both CK1δ and CK1ε.
• Chemical formula C23H19F3N8O and molecular weight 480.45.
• High purity (99.7%) suitable for research applications.
• Available as solid and as DMSO solution for experimental flexibility.

Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More

Medchemexpress LLC N-((6,7-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine | 1454585-06-8 | MFCD30187527 | 99.7% | 480.45 g·mol⁻1 | C23H19F3N8O | 2 MG

SR-3029 is a potent, ATP-competitive inhibitor of casein kinase 1 isoforms CK1δ and CK1ε used in biochemical and cellular research. It exhibits nanomolar inhibition of CK1δ and CK1ε and is supplied as a high-purity research compound suitable for in vitro and cell-based assays.

• Potent ATP-competitive inhibition of CK1δ (IC50 44 nM) and CK1ε (IC50 260 nM).
• Ki approximately 97 nM for both kinases.
• High reported purity (99.73%), appropriate for biochemical assays.
• Available as a solid or as a 10 mM solution in DMSO for convenient handling.
• Molecular weight 480.45 g·mol⁻1; formula C23H19F3N8O.
• Suitable for kinase profiling and cell-based studies.

Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More